Research and Innovation
Research and innovation are at the heart of ALIMA’s work. Our goal is to propose innovative solutions to meet the challenges of humanitarian medicine in the 21st century.
- Only 3.6% of research projects are conducted on the African continent.
- Some diseases and health issues lack research, especially in resource-limited countries. It is essential for low-income countries, as well as for humanitarian actors, to be able to rely on locally based research to improve patients care. This is why ALIMA is committed to developing projects that link medical research and humanitarian action in Africa.
research projects have been conducted by ALIMA since its creation in 2009
of ALIMA’s activity is focused on research in different areas of expertise (viral hemorrhagic fevers, malnutrition, respiratory distress and epidemics).
research projects are currently underway (preparation, implementation or analysis)
CORAL, a collaborative research platform
In 2016, ALIMA and its partners created a unique research model between Africa and Europe dedicated to humanitarian medical research, through an alliance between researchers, health workers and NGOs. This is how ALIMA, together with the Inserm 1219 GHiGS (Global Health in the Global South) team and PACCI (Franco-Ivorian research program) built the CORAL (Clinical and Operational Research Alliance) platform.
This clinical and operational research alliance aims to combat existing and emerging health threats in Africa. It proposes innovative solutions to improve the effectiveness of humanitarian medical interventions and relies on partnerships with local actors. CORAL is made up of two research poles: mother and child health and emerging infectious diseases.
Clinical research to better prevent and treat viral hemorrhagic fevers
In recent years, ALIMA has demonstrated its capacity to implement research projects in emergency health situations, particularly during outbreaks of viral hemorrhagic fevers. During the 2018-2019 Ebola outbreak in eastern Democratic Republic of Congo, ALIMA, with the PALM consortium, helped identify two treatments for Ebola that can now reduce mortality to less than 20%. Knowing that mortality rates in some epidemics have been as high as 90% of cases, this is a major breakthrough for our patients.
- The Ministries of Health in our countries of intervention
- Inserm –National Institute of Health and Medical Research (France)
- IRD – Institute of Research for Development
- ANRS-MIE –National Agency for Research on HIV/AIDS, Tuberculosis, Hepatitis and Emerging Infectious Diseases (France)
- PAC-CI –ANRS Emerging infectious diseases program (Ivory Coast)
- NIH –National Institutes of Health (USA)
- ISPED – Institute of Public Health, Epidemiology and Development (France)
- EDCTP – Europe-developing country partnership for clinical trials
- ALERRT – African Coalition for Epidemic Research Training and Response
- Innocent Foundation
- INRB – National Biomedical Research Institute (DRC)
- BNITM – Bernard Noch Institute of Tropical Medicine
- IMT – Institute of Tropical Medicine of Antwerp (Belgium)
- DnDi – Drugs for Neglected Diseases Initiative
- Trauma Aid France
- Givewell Foundation
- CRI Foundation
- WAM Foundation
Get involved with ALIMA!
Help us save more lives by donating
Become a member of ALIMA and take part in our projects
Join us to transform humanitarian medicine